Skip to main content
Premium Trial:

Request an Annual Quote

SAIC-Frederick to Use ABI s TaqMan Collection to Genotype Cancer Samples

NEW YORK, April 4 (GenomeWeb News) - The Core Genotyping Facility of SAIC-Frederick, a contractor for the National Cancer Institute, will use Applied Biosystems' genotyping assays to study genetic variations in a number of cancer samples, the two organizations said today.

 

SAIC-Frederick will use more than 2,400 of ABI's TaqMan drug metabolism genotyping assays to genotype samples from the International HapMap project and from NCI's SNP500Cancer standard sample panel. In addition, it will use a number of assays to genotype individuals from a study evaluating treatment for Non-Hodgkin's lymphoma.

 

ABI and the Core Genotyping Facility will jointly analyze the resulting genotyping data and plan to post their findings on the SNP500Cancer website and publish further findings. The aim of the study is to better understand genetic differences associated with responses to cancer treatment.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.